Jae Jung
Dermatology · Louisville, KYNPI 1013946375
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $142,336 of the $188,188 with a category attached, or 75.6%. Regeneron Healthcare Solutions, Inc. accounts for 65.6% of it on its own, with 10 other manufacturers making up the rest. Among dermatology clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 164 payments — averaging $1147.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$123K
- Sanofi$53K
- Sun Pharmaceutical Industries Inc.$7K
- Novocure Inc.$2K
- Kyowa Kirin, Inc.$2K
- Boston Scientific$239
- plus $572 from 5 others
Across 92 payments — averaging $5042.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$464K
What the payments were for
- Consulting fees$13,6567%
- Speaking & faculty fees$142,33676%
- Travel & lodging$27,61815%
- Food & beverage$4,5782%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 80 | $123,377 |
| Sanofi | 49 | $52,974 |
| Sun Pharmaceutical Industries Inc. | 9 | $7,247 |
| Novocure Inc. | 1 | $2,250 |
| Kyowa Kirin, Inc. | 15 | $1,529 |
| Boston Scientific | 4 | $239 |
| Merck | 2 | $133 |
| Array Biopharma Inc | 1 | $124 |
| Exelixis Inc. | 1 | $120 |
| Iovance Biotherapeutics, Inc. | 1 | $114 |
| E.r. Squibb & Sons, L.L.C. | 1 | $82 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LIBTAYO$174,626
- Unloxcyt$7,026
- NovoTTF-100L$2,250
- POTELIGEO$1,210
- GENERAL PAIN MANAGEMENT$145
- BRAFTOVI$124
- MEKTOVI$124
- KEYTRUDA$120
- Cabometyx$120
- Amtagvi$114
How this compares
$188,188 in reported general payments places this provider in the 95th percentile of 128 dermatology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 18 | $64,678 |
| XolairOmalizumab | 13 | $44,550 |
| Fluorouracil | 74 | $5,642 |
| Triamcinolone Acetonide | 230 | $3,884 |
| Clobetasol Propionate | 49 | $2,463 |
| Metronidazole | 29 | $1,190 |
| Betamethasone Dipropionate | 14 | $1,111 |
| Ketoconazole | 48 | $1,094 |
| Fluocinonide | 13 | $782 |
| Hydroxyzine Hcl | 94 | $736 |
| ValacyclovirValacyclovir Hcl | 28 | $694 |
| Mupirocin | 76 | $684 |
| Clindamycin Phosphate | 27 | $662 |
| Gentamicin Sulfate | 11 | $569 |
| MethotrexateMethotrexate Sodium | 43 | $403 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Louisville
- James JacksonLouisville$326K
- Clint TuckerLouisville$50K
- Mark WaldmanLouisville$33K
- Joseph FowlerLouisville$29K
- Shannon EnglandLouisville$20K
- Jeffrey CallenLouisville$18K
- Ashley BrownLouisville$16K
- Todd RickettLouisville$15K
- Margaret MoyeLouisville$13K
- Cindy OwenLouisville$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.